These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 12887186)

  • 1. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
    Lee SW; Markham PF; Coppo MJ; Legione AR; Shil NK; Quinteros JA; Noormohammadi AH; Browning GF; Hartley CA; Devlin JM
    Avian Dis; 2014 Mar; 58(1):147-52. PubMed ID: 24758128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.
    Korsa MG; Browning GF; Coppo MJ; Legione AR; Gilkerson JR; Noormohammadi AH; Vaz PK; Lee SW; Devlin JM; Hartley CA
    PLoS One; 2015; 10(9):e0137719. PubMed ID: 26366738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
    Vagnozzi A; Riblet S; Zavala G; Ecco R; Afonso CL; García M
    Avian Pathol; 2016; 45(1):106-13. PubMed ID: 26926298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
    Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
    Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
    Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
    Vagnozzi A; García M; Riblet SM; Zavala G
    Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.
    Thilakarathne DS; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Coppo MJC; Devlin JM
    Avian Pathol; 2020 Aug; 49(4):369-379. PubMed ID: 32352307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.
    Chacón JL; Núñez LF; Vejarano MP; Parra SH; Astolfi-Ferreira CS; Ferreira AJ
    Trop Anim Health Prod; 2015 Aug; 47(6):1101-8. PubMed ID: 25904510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
    Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.